Effect of levocarnitine administration in patients with chronic liver disease

L-carnitine administration was reported to improve sarcopenia in patients with cirrhosis. However, the amount of evidence from previous studies is not sufficient. The present study aimed to clarify the effect of levocarnitine (L-carnitine) administration on body composition in patients with chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Fujiko, Kobayashi, Miki, Hirosawa, Shiori, Sugiyama, Kaede, Mitobe, Yuta, Yoshida, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507016/
https://www.ncbi.nlm.nih.gov/pubmed/32973943
http://dx.doi.org/10.3892/etm.2020.9222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507016/
https://www.ncbi.nlm.nih.gov/pubmed/32973943
http://dx.doi.org/10.3892/etm.2020.9222

Ejemplares similares